BUZZ-泰罗米尔制药公司因表观遗传药物的早期数据而大涨

路透中文
Aug 28, 2025
BUZZ-泰罗米尔制药公司因表观遗传药物的早期数据而大涨

8月28日 - ** 药物开发商泰罗米尔制药公司TELO.O股价盘前大涨59%至2.35美元

** 周三晚些时候,该公司称其主要实验药物Telomir-1有望成为治疗癌症和老年相关疾病的一流 (link) 表观遗传疗法

** 该公司称,它能有效阻断基因调控酶UTX,并能帮助重置异常的DNA甲基化模式

** 对与肿瘤生长和炎症有关的其他表观遗传靶点也显示出选择性活性

** 表观遗传疗法旨在改变基因开启或关闭的方式,而不改变 DNA 本身

** 截至上次收盘,该公司股价年累计下跌 64

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10